CAROLINE BUEHLER: Open Payments
NPI 1679977078 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 24 payments from 10 companies in 2025. Trend: 2023 $302 · 2024 $569 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $106 |
| Arcutis Biotherapeutics, Inc. | 2 | $106 |
| ABBVIE INC. | 4 | $91 |
| Galderma Laboratories, L.P. | 4 | $75 |
| Incyte Corporation | 2 | $52 |
| GENZYME CORPORATION | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Botanix SB Inc | 1 | $24 |
| UCB, Inc. | 1 | $20 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $9 |
Products named: COSENTYX, Zoryve, NEMLUVIO, DUPIXENT, RINVOQ, OPZELURA, SOFDRA, SKYRIZI.
Industry payments across MD — which companies pay providers there.
